boosters O O O O
and O O O O
progress O O O O
toward O O O O
a O O O O
nasal O O O O
vaccine O O O O
This O O O O
episode O O O O
of O O O O
'Show O O O O
Me O O O O
the O O O O
Science' O O O O
details O O O O
the O O O O
nasal O O O O
vaccine O O O O
developed O O O O
by O O O O
WashU O O O O
Medicine O O O O
scientists; O O O O
plus, O O O O
new O O O O
mRNA O O O O
vaccine O O O O
boosters O O O O
as O O O O
cold O O O O
weather O O O O
approachesSara O O O O
Moser/Getty O O O O
Images O O O O
A O O O O
new O O O O
episode O O O O
of O O O O
our O O O O
podcast, O O O O
" O O O O
[Show O O O O
Me O O O O
the O O O O
Science](https://medicine.wustl.edu/news/type/podcast/)," O O O O
has O O O O
been O O O O
posted. O O O O
In O O O O
addition O O O O
to O O O O
reporting O O O O
on O O O O
the O O O O
state O O O O
of O O O O
the O O O O
COVID-19 O O O O
pandemic, O O O O
these O O O O
episodes O O O O
feature O O O O
stories O O O O
about O O O O
other O O O O
groundbreaking O O O O
research, O O O O
as O O O O
well O O O O
as O O O O
lifesaving O O O O
and O O O O
just O O O O
plain O O O O
cool O O O O
work O O O O
involving O O O O
faculty, O O O O
staff O O O O
and O O O O
students O O O O
at O O O O
Washington O O ScientificAuthority O
University O O ScientificAuthority O
School O O ScientificAuthority O
of O O ScientificAuthority O
Medicine O O ScientificAuthority O
in O O ScientificAuthority O
St. O O ScientificAuthority O
Louis. O O ScientificAuthority O
As O O O O
we O O O O
get O O O O
deeper O O O O
into O O O O
autumn O O O O
and O O O O
winter O O O O
approaches, O O O O
we O O O O
discuss O O O O
COVID-19 O O O O
vaccines. O O O O
New O O O O
boosters O O O O
have O O O O
been O O O O
developed O O O O
to O O O O
rev O O O O
up O O O O
the O O O O
immune O O O O
system O O O O
not O O O O
only O O O O
to O O O O
fight O O O O
the O O O O
original O O O O
strain O O O O
of O O O O
the O O O O
virus O O O O
but O O O O
also O O O O
to O O O O
boost O O O O
the O O O O
immune O O O O
system O O O O
against O O O O
more O O O O
recent O O O O
omicron O O O O
strains O O O O
of O O O O
SARS-CoV-2. O O O O
In O O O O
this O O O O
episode, O O O O
we O O O O
discuss O O O O
the O O O O
boosters O O O O
— O O O O
now O O O O
approved O O O O
for O O O O
use O O O O
in O O O O
children O O O O
as O O O O
young O O O O
as O O O O
5 O O O O
— O O O O
with O O O O
infectious O O O O
diseases O O O O
specialist O O O O
[Rachel O O O O
M. O O O O
Presti, O O O O
MD, O O O O
PhD](https://infectiousdiseases.wustl.edu/people/rachel-presti/), O O O O
an O O O O
associate O O O O
professor O O O O
of O O O O
medicine O O O O
and O O O O
medical O O O O
director O O O O
of O O O O
Washington O O ScientificAuthority O
University's O O ScientificAuthority O
[Infectious O O ScientificAuthority O
Diseases O O ScientificAuthority O
Clinical O O ScientificAuthority O
Research O O ScientificAuthority O
Unit](https://infectiousdiseases.wustl.edu/patient-care/clinical-trials/). O O ScientificAuthority O
New O O O O
vaccines O O O O
may O O O O
be O O O O
on O O O O
the O O O O
horizon, O O O O
too. O O O O
A Reason 5 O O
nasal Reason 5 O O
vaccine Reason 5 O O
developed Reason 5 O O
by Reason 5 O O
Washington Reason 5 ScientificAuthority O
University Reason 5 ScientificAuthority O
scientists Reason 5 O O
recently Reason 5 O O
was Reason 5 O O
approved Reason 5 O O
for Reason 5 O O
emergency Reason 5 O O
use Reason 5 O O
in Reason 5 O O
India, Reason 5 O O
and Reason 5 O O
that Reason 5 O O
technology Reason 5 O O
has Reason 5 O O
been Reason 5 O O
licensed Reason 5 O O
to Reason 5 O O
Ocugen, Reason 5 O O
a Reason 5 O O
U.S.-based Reason 5 O O
biotechnology Reason 5 O O
company Reason 5 O O
focused Reason 5 O O
on Reason 5 O O
developing Reason 5 O O
and Reason 5 O O
commercializing Reason 5 O O
novel Reason 5 O O
gene Reason 5 O O
and Reason 5 O O
cell Reason 5 O O
therapies Reason 5 O O
and Reason 5 O O
vaccines. Reason 5 O O
Ocugen Reason 5 O O
plans Reason 5 O O
to Reason 5 O O
seek Reason 5 O O
approval Reason 5 O O
for Reason 5 O O
the Reason 5 O O
nasal Reason 5 O O
vaccine Reason 5 O O
in Reason 5 O O
the Reason 5 O O
U.S., Reason 5 O O
Europe Reason 5 O O
and Reason 5 O O
Japan. Reason 5 O O
The Reason 5 O O
nasal Reason 5 O O
vaccine Reason 5 O O
was Reason 5 O O
developed Reason 5 O O
by Reason 5 O O
Washington Reason 5 ScientificAuthority O
University Reason 5 ScientificAuthority O
virologist Reason 5 O O
and Reason 5 O O
immunologist Reason 5 O O
[Michael Reason 5 O O
S. Reason 5 O O
Diamond, Reason 5 O O
MD, Reason 5 O O
PhD](https://infectiousdiseases.wustl.edu/people/michael-s-diamond/), Reason 5 O O
the Reason 5 O O
Herbert Reason 5 O O
S. Reason 5 O O
Gasser Reason 5 O O
Professor Reason 5 O O
of Reason 5 O O
Medicine Reason 5 O O
and Reason 5 O O
a Reason 5 O O
professor Reason 5 O O
of Reason 5 O O
molecular Reason 5 O O
microbiology, Reason 5 O O
and Reason 5 O O
of Reason 5 O O
pathology Reason 5 O O
& Reason 5 O O
immunology; Reason 5 O O
and Reason 5 O O
[David Reason 5 O O
T. Reason 5 O O
Curiel, Reason 5 O O
MD, Reason 5 O O
PhD](https://radonc.wustl.edu/people/david-t-curiel-md-phd/), Reason 5 O O
the Reason 5 O O
Distinguished Reason 5 O O
Professor Reason 5 O O
of Reason 5 O O
Radiation Reason 5 O O
Oncology. Reason 5 O O
The Reason 5 O O
hope Reason 5 O O
is Reason 5 O O
that Reason 5 O O
the Reason 5 O O
nasal Reason 5 O O
vaccine Reason 5 O O
will Reason 5 O O
stoke Reason 5 O O
the Reason 5 O O
immune Reason 5 O O
response Reason 5 O O
in Reason 5 O O
the Reason 5 O O
nose Reason 5 O O
and Reason 5 O O
throat Reason 5 O O
so Reason 5 O O
that Reason 5 O O
the Reason 5 O O
virus Reason 5 O O
never Reason 5 O O
gets Reason 5 O O
farther Reason 5 O O
into Reason 5 O O
the Reason 5 O O
body. Reason 5 O O
Current Reason 5 O O
vaccines Reason 5 O O
require Reason 5 O O
a Reason 5 O O
person Reason 5 O O
to Reason 5 O O
be Reason 5 O O
infected Reason 5 O O
before Reason 5 O O
antibodies Reason 5 O O
revved Reason 5 O O
up Reason 5 O O
by Reason 5 O O
the Reason 5 O O
vaccine Reason 5 O O
can Reason 5 O O
fight Reason 5 O O
it. Reason 5 O O
As Reason 5 O O
a Reason 5 O O
result, Reason 5 O O
Diamond Reason 5 O O
and Reason 5 O O
Curiel Reason 5 O O
say Reason 5 O O
a Reason 5 O O
nasal Reason 5 O O
spray Reason 5 O O
may Reason 5 O O
be Reason 5 O O
more Reason 5 O O
effective Reason 5 O O
at Reason 5 O O
preventing Reason 5 O O
infections Reason 5 O O
and Reason 5 O O
at Reason 5 O O
keeping Reason 5 O O
vaccinated Reason 5 O O
people Reason 5 O O
from Reason 5 O O
spreading Reason 5 O O
the Reason 5 O O
virus Reason 5 O O
to Reason 5 O O
others. Reason 5 O O
The O O O O
podcast, O O O O
"Show O O O O
Me O O O O
the O O O O
Science," O O O O
is O O O O
produced O O O O
by O O O O
the O O O O
[Office O O O O
of O O O O
Medical O O O O
Public O O O O
Affairs](https://marcomm.med.wustl.edu) O O O O
at O O O O
Washington O O ScientificAuthority O
University O O ScientificAuthority O
School O O ScientificAuthority O
of O O ScientificAuthority O
Medicine O O ScientificAuthority O
in O O ScientificAuthority O
St. O O ScientificAuthority O
Louis. O O ScientificAuthority O
Transcript O O O O
Jim O O O O
Dryden O O O O
(host): O O O O
Hello O O O O
and O O O O
welcome O O O O
to O O O O
"Show O O O O
Me O O O O
the O O O O
Science," O O O O
conversations O O O O
about O O O O
science O O O O
and O O O O
health O O O O
with O O O O
the O O O O
people O O O O
of O O O O
Washington O O ScientificAuthority O
University O O ScientificAuthority O
School O O ScientificAuthority O
of O O ScientificAuthority O
Medicine O O ScientificAuthority O
in O O ScientificAuthority O
St. O O ScientificAuthority O
Louis, O O ScientificAuthority O
Missouri O O O O
... O O O O
the O O O O
Show-Me O O O O
State. O O O O
During O O O O
the O O O O
first O O O O
two O O O O
years O O O O
that O O O O
we O O O O
produced O O O O
this O O O O
podcast, O O O O
we O O O O
focused O O O O
entirely O O O O
on O O O O
how O O O O
School O O O O
of O O O O
Medicine O O O O
doctors, O O O O
researchers O O O O
and O O O O
trainees O O O O
responded O O O O
to O O O O
the O O O O
COVID-19 O O O O
pandemic. O O O O
Now, O O O O
as O O O O
the O O O O
pandemic, O O O O
we O O O O
hope, O O O O
is O O O O
receding O O O O
just O O O O
a O O O O
little, O O O O
we O O O O
also O O O O
are O O O O
reporting O O O O
on O O O O
some O O O O
of O O O O
the O O O O
other O O O O
research, O O O O
lifesaving O O O O
and O O O O
just O O O O
plain O O O O
cool O O O O
work O O O O
being O O O O
done O O O O
at O O O O
the O O O O
School O O O O
of O O O O
Medicine. O O O O
But O O O O
fall O O O O
has O O O O
arrived, O O O O
and O O O O
so O O O O
have O O O O
new O O O O
COVID O O O O
vaccines. O O O O
FDA-approved O O ScientificAuthority O
boosters O O O O
now O O O O
are O O O O
designed O O O O
to O O O O
boost O O O O
the O O O O
body's O O O O
immune O O O O
response O O O O
not O O O O
only O O O O
against O O O O
the O O O O
original O O O O
strains O O O O
of O O O O
SARS-CoV-2 O O O O
but O O O O
also O O O O
against O O O O
more O O O O
recent O O O O
omicron O O O O
strains. O O O O
In O O O O
addition, O O O O
Washington O O ScientificAuthority O
University O O ScientificAuthority O
researchers O O O O
have O O O O
developed O O O O
a O O O O
nasal O O O O
vaccine. O O O O
It O O O O
was O O O O
the O O O O
first O O O O
in O O O O
the O O O O
world O O O O
to O O O O
be O O O O
approved O O O O
when O O O O
it O O O O
recently O O O O
was O O O O
approved O O O O
for O O O O
emergency O O O O
use O O O O
in O O O O
India. O O O O
Now O O O O
it O O O O
may O O O O
be O O O O
on O O O O
the O O O O
path O O O O
to O O O O
being O O O O
available O O O O
in O O O O
the O O O O
U.S., O O O O
Europe O O O O
and O O O O
Japan O O O O
after O O O O
Washington O O ScientificAuthority O
University O O ScientificAuthority O
licensed O O O O
the O O O O
technology O O O O
to O O O O
Ocugen, O O O O
a O O O O
U.S.-based O O O O
biotechnology O O O O
company O O O O
focused O O O O
on O O O O
developing O O O O
and O O O O
commercializing O O O O
novel O O O O
gene O O O O
and O O O O
cell O O O O
therapies O O O O
and O O O O
vaccines. O O O O
Dr. Reason 4 O O
David Reason 4 O O
Curiel Reason 4 O O
and Reason 4 O O
Dr. Reason 4 O O
Michael Reason 4 O O
Diamond Reason 4 O O
began Reason 4 O O
work Reason 4 O O
on Reason 4 O O
the Reason 4 O O
nasal Reason 4 O O
vaccine Reason 4 O O
during Reason 4 O O
the Reason 4 O O
early Reason 4 O O
days Reason 4 O O
of Reason 4 O O
the Reason 4 O O
pandemic, Reason 4 O O
when Reason 4 O O
mRNA Reason 4 O O
vaccines Reason 4 O O
also Reason 4 O O
were Reason 4 O O
being Reason 4 O O
developed. Reason 4 O O
But Reason 4 O O
Curiel, Reason 4 O O
who Reason 4 O O
had Reason 4 O O
some Reason 4 O O
experience Reason 4 O O
with Reason 4 O O
the Reason 4 O O
mRNA Reason 4 O O
platform, Reason 4 O O
says Reason 4 O O
the Reason 4 O O
researchers Reason 4 O O
always Reason 4 O O
thought Reason 4 O O
their Reason 4 O O
approach Reason 4 O O
to Reason 4 O O
nasal Reason 4 O O
vaccination Reason 4 O O
was Reason 4 O O
a Reason 4 O O
good Reason 4 O O
idea. Reason 4 O O
David O O O O
Curiel, O O O O
MD, O O O O
PhD: O O O O
The O O O O
most O O O O
important O O O O
issue O O O O
we O O O O
were O O O O
trying O O O O
to O O O O
address O O O O
was O O O O
the O O O O
transmission O O O O
problem, O O O O
so O O O O
that's O O O O
what O O O O
Mike O O O O
early O O O O
on O O O O
showed O O O O
we O O O O
gained O O O O
with O O O O
the O O O O
intranasal O O O O
route. O O O O
That O O O O
was O O O O
one O O O O
of O O O O
the O O O O
contexts O O O O
that O O O O
the O O O O
current O O O O
vaccines O O O O
didn't O O O O
address. O O O O
Dryden: Reason 5 O O
The Reason 5 O O
idea Reason 5 O O
behind Reason 5 O O
developing Reason 5 O O
a Reason 5 O O
nasal Reason 5 O O
vaccine Reason 5 O O
is Reason 5 O O
to Reason 5 O O
amp Reason 5 O O
up Reason 5 O O
the Reason 5 O O
immune Reason 5 O O
response Reason 5 O O
in Reason 5 O O
the Reason 5 O O
nose Reason 5 O O
and Reason 5 O O
the Reason 5 O O
throat, Reason 5 O O
where Reason 5 O O
the Reason 5 O O
virus Reason 5 O O
first Reason 5 O O
gets Reason 5 O O
into Reason 5 O O
the Reason 5 O O
body, Reason 5 O O
rather Reason 5 O O
than Reason 5 O O
the Reason 5 O O
current Reason 5 O O
vaccines Reason 5 O O
that Reason 5 O O
fight Reason 5 O O
the Reason 5 O O
infection Reason 5 O O
once Reason 5 O O
it's Reason 5 O O
already Reason 5 O O
in Reason 5 O O
the Reason 5 O O
system. Reason 5 O O
In Reason 5 O O
theory, Reason 5 O O
a Reason 5 O O
nasal Reason 5 O O
vaccine Reason 5 O O
also Reason 5 O O
would Reason 5 O O
make Reason 5 O O
it Reason 5 O O
harder Reason 5 O O
for Reason 5 O O
vaccinated Reason 5 O O
people Reason 5 O O
to Reason 5 O O
infect Reason 5 O O
others, Reason 5 O O
because Reason 5 O O
while Reason 5 O O
shots Reason 5 O O
that Reason 5 O O
deliver Reason 5 O O
the Reason 5 O O
current Reason 5 O O
vaccines Reason 5 O O
put Reason 5 O O
antibodies Reason 5 O O
in Reason 5 O O
the Reason 5 O O
immune Reason 5 O O
system Reason 5 O O
on Reason 5 O O
the Reason 5 O O
lookout Reason 5 O O
for Reason 5 O O
the Reason 5 O O
virus, Reason 5 O O
the Reason 5 O O
virus Reason 5 O O
still Reason 5 O O
does Reason 5 O O
have Reason 5 O O
to Reason 5 O O
get Reason 5 O O
into Reason 5 O O
the Reason 5 O O
body Reason 5 O O
first. Reason 5 O O
So Reason 5 O O
the Reason 5 O O
nose, Reason 5 O O
where Reason 5 O O
the Reason 5 O O
virus Reason 5 O O
enters, Reason 5 O O
might Reason 5 O O
be Reason 5 O O
a Reason 5 O O
more Reason 5 O O
effective Reason 5 O O
place Reason 5 O O
to Reason 5 O O
stop Reason 5 O O
it. Reason 5 O O
And O O O O
when O O O O
Curiel O O O O
and O O O O
Diamond O O O O
compared O O O O
the O O O O
vaccination O O O O
approaches O O O O
in O O O O
mice, O O O O
Michael O O O O
Diamond O O O O
says O O O O
the O O O O
nasal O O O O
approach O O O O
worked O O O O
better. O O O O
Michael Reason 5 O O
S. Reason 5 O O
Diamond, Reason 5 O O
MD, Reason 5 O O
PhD: Reason 5 O O
We Reason 5 O O
did Reason 5 O O
a Reason 5 O O
study Reason 5 O O
in Reason 5 O O
the Reason 5 O O
laboratory, Reason 5 O O
where Reason 5 O O
we Reason 5 O O
head-to-head Reason 5 O O
compared Reason 5 O O
intramuscular Reason 5 O O
vaccination Reason 5 O O
and Reason 5 O O
intranasal Reason 5 O O
vaccination Reason 5 O O
with Reason 5 O O
the Reason 5 O O
same Reason 5 O O
vaccine Reason 5 O O
and Reason 5 O O
the Reason 5 O O
same Reason 5 O O
dose. Reason 5 O O
And Reason 5 O O
what Reason 5 O O
we Reason 5 O O
saw Reason 5 O O
was Reason 5 O O
superior Reason 5 O O
results Reason 5 O O
when Reason 5 O O
we Reason 5 O O
gave Reason 5 O O
it Reason 5 O O
by Reason 5 O O
intranasal Reason 5 O O
route. Reason 5 O O
But Reason 5 O O
we Reason 5 O O
felt, Reason 5 O O
once Reason 5 O O
we Reason 5 O O
saw Reason 5 O O
those Reason 5 O O
results, Reason 5 O O
that Reason 5 O O
this Reason 5 O O
kind Reason 5 O O
of Reason 5 O O
a Reason 5 O O
vaccine Reason 5 O O
would Reason 5 O O
have Reason 5 O O
the Reason 5 O O
opportunity Reason 5 O O
to Reason 5 O O
restrict Reason 5 O O
transmission Reason 5 O O
or Reason 5 O O
to Reason 5 O O
cut Reason 5 O O
down Reason 5 O O
transmission Reason 5 O O
substantially, Reason 5 O O
whereas Reason 5 O O
the Reason 5 O O
other Reason 5 O O
ones Reason 5 O O
wouldn't. Reason 5 O O
Dryden: O O O O
Meanwhile, O O O O
new O O O O
mRNA O O O O
boosters O O O O
are O O O O
available O O O O
now O O O O
in O O O O
the O O O O
United O O O O
States, O O O O
approved O O O O
for O O O O
use O O O O
in O O O O
children O O O O
as O O O O
young O O O O
as O O O O
5 O O O O
or O O O O
6, O O O O
depending O O O O
on O O O O
whether O O O O
it's O O O O
the O O O O
Pfizer O O O O
or O O O O
the O O O O
Moderna O O O O
shot O O O O
